# Metabolic Landscape of Endometrial Cancer: Insights into Pathway Dysregulation and Metabolic Features

**Authors:** Qing Yang, Xiaoli Tian, Min Hu, Wenjing Ma, Qingzhen Xie, Jingchun Liu, Li Hong

PMC · DOI: 10.3390/biomedicines14010202 · Biomedicines · 2026-01-17

## TL;DR

This study identifies unique metabolic patterns in endometrial cancer tissues, highlighting key metabolites that could aid in diagnosis and understanding the disease's biology.

## Contribution

The novel contribution is the identification of six key metabolites through machine learning that distinguish endometrial cancer from normal tissue.

## Key findings

- 300 metabolites were found to be significantly altered in endometrial cancer tissues.
- Tumor tissues showed increased sphingolipid and glutathione metabolism, and decreased bile acid and steroid biosynthesis.
- Six key metabolites were identified with strong tissue-discriminative potential using machine learning.

## Abstract

Background: Metabolic reprogramming is increasingly recognized as a hallmark of endometrial cancer, yet tissue-based metabolic signatures remain insufficiently defined. Methods: Untargeted metabolomics was performed on paired endometrial cancer (n = 10) and adjacent normal tissues (n = 10). Differential metabolites were identified through multivariate and univariate analyses. KEGG enrichment characterized altered pathways, while Random Forest and SVM were used for machine-learning-based feature prioritization. ROC analyses were conducted to evaluate the discriminative potential of selected metabolites. Results: 300 metabolites were significantly altered. Tumor tissues showed increased sphingolipid metabolism, glutathione metabolism, and arachidonic acid metabolism, alongside decreased bile acid, phenylalanine, and steroid biosynthesis. Machine learning converged on six key metabolites that demonstrate strong tissue-discriminative capacity. Conclusions: Endometrial cancer exhibits a distinct metabolic profile characterized by lipid remodeling and redox adaptation. The six metabolites identified through machine-learning-based analyses represent candidate metabolic features associated with endometrial cancer and provide a foundation for future mechanistic studies and validation in larger, independent cohorts.

## Linked entities

- **Diseases:** endometrial cancer (MONDO:0002447)

## Full-text entities

- **Diseases:** Endometrial Cancer (MESH:D016889), Tumor (MESH:D009369)
- **Chemicals:** bile acid (MESH:D001647), steroid (MESH:D013256), metabolites (-), sphingolipid (MESH:D013107), glutathione (MESH:D005978), lipid (MESH:D008055), arachidonic acid (MESH:D016718), phenylalanine (MESH:D010649)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12838860/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12838860/full.md

## References

38 references — full list in the complete paper: https://tomesphere.com/paper/PMC12838860/full.md

---
Source: https://tomesphere.com/paper/PMC12838860